MeVis Medical Solutions AGFRA:M3V 66 Shareholder Yield % is 3.93% as of Mar. 2026, which is 26% above its 10-year median of 3.12. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.72. The stock has 5 warning signs investors should review. Among 654 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks better than 73.09% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, MeVis Medical Solutions AG's Shareholder Yield % was 3.93%.
MeVis Medical Solutions AG (FRA:M3V) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
MeVis Medical Solutions AG Shareholder Yield % Related Terms
MeVis Medical Solutions AG Shareholder Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG Shareholder Yield % Chart
FRA:M3V vs VEEV, BTSG, TEM: Shareholder Yield % Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG Shareholder Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
MeVis Medical Solutions AG (FRA:M3V) has a Shareholder Yield % of 3.93% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on MeVis Medical Solutions AG and its competitors. This is 26% above median its historical median of 3.12. According to the industry distribution chart, MeVis Medical Solutions AG ranks #176 out of 654 companies in the Healthcare Providers & Services industry, placing it in the top 26.9%.
Is MeVis Medical Solutions AG's Shareholder Yield % too high?
MeVis Medical Solutions AG's current Shareholder Yield % of 3.93% is 26% above median its 10-year median of 3.12. The Healthcare Providers & Services industry median Shareholder Yield % is 0.08. MeVis Medical Solutions AG's value of 3.93% is 5140% above this industry median. Based on the distribution chart, MeVis Medical Solutions AG ranks #176 out of 654 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's Shareholder Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #176 out of 654 companies for Shareholder Yield %. This puts MeVis Medical Solutions AG in the upper half of its industry. The industry median Shareholder Yield % is 0.08. MeVis Medical Solutions AG's value of 3.93% is 5140% above this benchmark. While the company's 10-year median is 3.12 vs. the industry median of 0.08, MeVis Medical Solutions AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Healthcare Providers & Services company?
The median Shareholder Yield % among Healthcare Providers & Services companies is 0.08, based on 654 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MeVis Medical Solutions AG's current Shareholder Yield % of 3.93% is 5140% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on MeVis Medical Solutions AG and its competitors. For the Healthcare Providers & Services industry, the median Shareholder Yield % is 0.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current Shareholder Yield % is 3.93%, which is 26% above median its own 10-year median of 3.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current Shareholder Yield % of 3.93%. The stock's GF Value™ is €22.72, compared to a current price of €24.00 — trading 5.6% above its estimated fair value. The current Shareholder Yield % is 3.93%, which is 26% above median its 10-year median of 3.12 and 5140% above the Healthcare Providers & Services industry median of 0.08. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current Shareholder Yield % is 3.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €24.00 is trading 5.6% above its estimated GF Value™ of €22.72.
Key valuation signals for FRA:M3V:
Shareholder Yield %: 3.93% (26% above median its 10-year median of 3.12)
GF Value™: €22.72 vs. price of €24.00 (5.6% above fair value)
Industry Position: 5140% above the Healthcare Providers & Services median (#176 of 654)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score
Get the complete analysis for FRA:M3V
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
